Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
VisiRose Logo
VisiRose Growth Score
52
CB Rank
63647
Heat Score
37
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases.
Founded
obfuscation
PrivateSeed Knoxville, Tennessee, United States1-10 visirose.com
Biotechnology
Health Care
Medical
Overview

VisiRose
Total Funding
obfuscation
Growth Score
52
Heat Score
37

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score52
-4 pts
in past quarter
Heat Score 37
20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About VisiRose

CB Rank
63647
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases.
Founded
obfuscation
PrivateSeed Knoxville, Tennessee, United States1-10 visirose.com
Biotechnology
Health Care
Medical

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name VisiRose, Inc
Operating Status Active
Company Type For Profit
Founders  Heather Raines
About the Company
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases.
Contact Email contact@visirose.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT)
A non-invasive treatment combining rose bengal sodium and light activation to treat infectious keratitis and other eye infections caused by bacteria, fungi, and parasites.
PV-305
An investigational eye drug candidate based on rose bengal sodium for photodynamic therapy targeting corneal blindness and severe ocular conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed
obfuscation
Seed Round - VisiRose Logo
Seed Round - VisiRose
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Mar 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

92

IT Spend

$65.3KThis year, VisiRose is projected to spend $65.3K on IT, according to Aberdeen.

Active Website Tech Count

5VisiRose is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, Viewport Meta, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is VisiRose's headquarters? VisiRose is located in Knoxville, Tennessee, United States.When was the last funding round for VisiRose? VisiRose closed its last funding round on
obfuscation
from a Seed round.Who are VisiRose's competitors? Alternatives and possible competitors to VisiRose may include NovaBay Pharmaceuticals.How much funding has VisiRose raised to date? VisiRose has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|